Atlas Trials

A Study of the Use of Hepatitis C Positive Donors for Hepatitis C Negative Lung Transplant Recipients With Post-transplant Treatment With Mavyret

Clinical trial NCT03523871 · COMPLETED

Trial details

NCT number
NCT03523871
Sponsor
NYU Langone Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C
Start date
2018-05-12
Primary completion
2020-09-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.